Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien

Susanne Rabady; Johann Altenberger; Markus Brose; Doris-Maria Denk-Linnert; Elisabeth Fertl; Florian Götzinger; Maria de la Cruz Gomez Pellin; Benedikt Hofbaur; Kathryn Hoffmann; Renate Hoffmann-Dorninger; Rembert Koczulla; Oliver Lammel; Bernd Lamprecht; Judith Löffler-Ragg; Christian A Müller; Stefanie Poggenburg; Hans Rittmannsberger; Paul Sator; Volker Strenger; Karin Vonbank; Johannes Wancata; Thomas Weber; Jörg Weber; Günter Weiss; Maria Wendler; Ralf-Harun Zwick

doi:10.1007/s00508-021-01974-0

Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien

Translated title of the contribution: Guideline S1: Long COVID: Diagnostics and treatment strategies

Susanne Rabady, Johann Altenberger, Markus Brose, Doris-Maria Denk-Linnert, Elisabeth Fertl, Florian Götzinger, Maria de la Cruz Gomez Pellin, Benedikt Hofbaur, Kathryn Hoffmann, Renate Hoffmann-Dorninger, Rembert Koczulla, Oliver Lammel, Bernd Lamprecht, Judith Löffler-Ragg, Christian A Müller, Stefanie Poggenburg, Hans Rittmannsberger, Paul Sator, Volker Strenger, Karin VonbankJohannes Wancata, Thomas Weber, Jörg Weber, Günter Weiss, Maria Wendler, Ralf-Harun Zwick

Division of General and Family Medicine

Research output: Journal article (peer-reviewed) › Journal article

6 Citations (Scopus)

Abstract

This guideline comprises the state of science at the time of the editorial deadline. In view of the high turnover of knowledge the guideline is designed as a living guideline. The main objective was to provide a tool for the use in primary care, being considered well suited as a first point of entry and for the provision of care. The guideline gives recommendations on the differential diagnosis of symptoms following SARS-CoV‑2 infection, on their therapeutic options, as well as for guidance and care of the patients concerned. It also offers advice concerning return to daily life and rehabilitation. Long COVID being a very variable condition, we chose an interdisciplinary approach.

Translated title of the contribution	Guideline S1: Long COVID: Diagnostics and treatment strategies
Original language	German
Pages (from-to)	237-278
Number of pages	42
Journal	Wiener Klinische Wochenschrift
Volume	133
Issue number	Suppl 7
DOIs	https://doi.org/10.1007/s00508-021-01974-0
Publication status	Published - Dec 2021

Access to Document

10.1007/s00508-021-01974-0

Cite this

Rabady, S., Altenberger, J., Brose, M., Denk-Linnert, D-M., Fertl, E., Götzinger, F., de la Cruz Gomez Pellin, M., Hofbaur, B., Hoffmann, K., Hoffmann-Dorninger, R., Koczulla, R., Lammel, O., Lamprecht, B., Löffler-Ragg, J., Müller, C. A., Poggenburg, S., Rittmannsberger, H., Sator, P., Strenger, V., ... Zwick, R-H. (2021). Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Wiener Klinische Wochenschrift, 133(Suppl 7), 237-278. https://doi.org/10.1007/s00508-021-01974-0

@article{d365f1ddc54e45adae1a84fd20d0f84c,

title = "Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien",

abstract = "This guideline comprises the state of science at the time of the editorial deadline. In view of the high turnover of knowledge the guideline is designed as a living guideline. The main objective was to provide a tool for the use in primary care, being considered well suited as a first point of entry and for the provision of care. The guideline gives recommendations on the differential diagnosis of symptoms following SARS-CoV‑2 infection, on their therapeutic options, as well as for guidance and care of the patients concerned. It also offers advice concerning return to daily life and rehabilitation. Long COVID being a very variable condition, we chose an interdisciplinary approach.",

keywords = "COVID-19/complications, Humans, SARS-CoV-2",

author = "Susanne Rabady and Johann Altenberger and Markus Brose and Doris-Maria Denk-Linnert and Elisabeth Fertl and Florian G{\"o}tzinger and {de la Cruz Gomez Pellin}, Maria and Benedikt Hofbaur and Kathryn Hoffmann and Renate Hoffmann-Dorninger and Rembert Koczulla and Oliver Lammel and Bernd Lamprecht and Judith L{\"o}ffler-Ragg and M{\"u}ller, {Christian A} and Stefanie Poggenburg and Hans Rittmannsberger and Paul Sator and Volker Strenger and Karin Vonbank and Johannes Wancata and Thomas Weber and J{\"o}rg Weber and G{\"u}nter Weiss and Maria Wendler and Ralf-Harun Zwick",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1007/s00508-021-01974-0",

language = "Deutsch",

volume = "133",

pages = "237--278",

journal = "Wiener Klinische Wochenschrift",

issn = "0043-5325",

publisher = "Springer-Verlag Wien",

number = "Suppl 7",

}

Rabady, S, Altenberger, J, Brose, M, Denk-Linnert, D-M, Fertl, E, Götzinger, F, de la Cruz Gomez Pellin, M, Hofbaur, B, Hoffmann, K, Hoffmann-Dorninger, R, Koczulla, R, Lammel, O, Lamprecht, B, Löffler-Ragg, J, Müller, CA, Poggenburg, S, Rittmannsberger, H, Sator, P, Strenger, V, Vonbank, K, Wancata, J, Weber, T, Weber, J, Weiss, G, Wendler, M & Zwick, R-H 2021, 'Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien', Wiener Klinische Wochenschrift, vol. 133, no. Suppl 7, pp. 237-278. https://doi.org/10.1007/s00508-021-01974-0

TY - JOUR

T1 - Leitlinie S1

T2 - Long COVID: Differenzialdiagnostik und Behandlungsstrategien

AU - Rabady, Susanne

AU - Altenberger, Johann

AU - Brose, Markus

AU - Denk-Linnert, Doris-Maria

AU - Fertl, Elisabeth

AU - Götzinger, Florian

AU - de la Cruz Gomez Pellin, Maria

AU - Hofbaur, Benedikt

AU - Hoffmann, Kathryn

AU - Hoffmann-Dorninger, Renate

AU - Koczulla, Rembert

AU - Lammel, Oliver

AU - Lamprecht, Bernd

AU - Löffler-Ragg, Judith

AU - Müller, Christian A

AU - Poggenburg, Stefanie

AU - Rittmannsberger, Hans

AU - Sator, Paul

AU - Strenger, Volker

AU - Vonbank, Karin

AU - Wancata, Johannes

AU - Weber, Thomas

AU - Weber, Jörg

AU - Weiss, Günter

AU - Wendler, Maria

AU - Zwick, Ralf-Harun

PY - 2021/12

Y1 - 2021/12

N2 - This guideline comprises the state of science at the time of the editorial deadline. In view of the high turnover of knowledge the guideline is designed as a living guideline. The main objective was to provide a tool for the use in primary care, being considered well suited as a first point of entry and for the provision of care. The guideline gives recommendations on the differential diagnosis of symptoms following SARS-CoV‑2 infection, on their therapeutic options, as well as for guidance and care of the patients concerned. It also offers advice concerning return to daily life and rehabilitation. Long COVID being a very variable condition, we chose an interdisciplinary approach.

AB - This guideline comprises the state of science at the time of the editorial deadline. In view of the high turnover of knowledge the guideline is designed as a living guideline. The main objective was to provide a tool for the use in primary care, being considered well suited as a first point of entry and for the provision of care. The guideline gives recommendations on the differential diagnosis of symptoms following SARS-CoV‑2 infection, on their therapeutic options, as well as for guidance and care of the patients concerned. It also offers advice concerning return to daily life and rehabilitation. Long COVID being a very variable condition, we chose an interdisciplinary approach.

KW - COVID-19/complications

KW - Humans

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85120381200&partnerID=8YFLogxK

U2 - 10.1007/s00508-021-01974-0

DO - 10.1007/s00508-021-01974-0

M3 - Artikel in Fachzeitschrift

C2 - 34851455

SN - 0043-5325

VL - 133

SP - 237

EP - 278

JO - Wiener Klinische Wochenschrift

JF - Wiener Klinische Wochenschrift

IS - Suppl 7

ER -

Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien

Abstract

Access to Document

Other files and links

Fingerprint

Cite this